Forbes THE MIDDLE EAST'S Top 100 HealthCare Leaders 2023 Dr.Sherine Hassan Helmy
04 May 2023
Pharco is currently working on an African project, “A Billion Lives Matter” which aims to test and treat 90% of Hepatitis B and C patients in Africa by 2030. “To help humankind by creating new, high-quality products and have them available to the consumer at affordable prices,” says Dr. Sherine Hassan Helmy, CEO of Pharco Pharmaceuticals.For years Egypt had the highest number of Hepatitis C Virus (HCV) cases in the world, but thanks to a national screening and treatment program launched by the Egyptian government in 2014, where Pharco Pharmaceuticals played its part by creating and producing affordable and effective direct-acting antivirals. And by 2020, Egypt had screened more than 60 million people for HCV and successfully treated over four million.
Read more